— Know what they know.
Not Investment Advice
Also trades as: 2142.HK (HKSE) · $vol 12M

HBMHF OTC

HBM Holdings Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -38.1% 1Y: -8.8%
$1.56
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 42 · $1.3B mcap · 562M float · 0.0000% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$38M -57.4% ▼
5Y CAGR: +47.5%
Gross Profit
$34M -61.6% ▼
5Y CAGR: +118.4%
Operating Income
-$2M -110.0% ▼
Net Income
$3M -87.8% ▼
EPS (Diluted)
$0.00 -88.3% ▼
EBITDA
$10M -67.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$14M$4M$41M$90M$38M
YoY Growth+159.0%-69.6%+849.2%+119.6%-57.4%
Cost of Revenue$6M$7M$8M$2M$4M
Gross Profit$8M-$3M$33M$87M$34M
Gross Margin59.7%-61.2%79.9%97.7%88.2%
R&D Expenses$51M$102M$130M$45M$21M
SG&A Expenses$39M$38M$25M$21M$8M
Operating Expenses$90M$140M$155M$66M$36M
Operating Income-$81M-$143M-$122M$22M-$2M
Operating Margin-576.3%-3319.4%-299.8%24.4%-5.7%
Interest Expense$280K$175K$2M$4M$4M
Income Before Tax-$297M-$137M-$137M$23M$4M
Tax Expense-$99K$49K$249K-$81K$997K
Net Income-$296M-$137M-$138M$23M$3M
Net Margin-2101.1%-3198.2%-337.5%25.5%7.3%
EPS (Diluted)$-0.39$-0.19$-0.19$0.03$0.00
EBITDA-$291M-$131M-$127M$31M$10M
Shares Outstanding757M732M729M743M772M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms